iA Global Asset Management Inc. Buys 5,136 Shares of HCA Healthcare, Inc. $HCA

iA Global Asset Management Inc. boosted its position in HCA Healthcare, Inc. (NYSE:HCA) by 12.9% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 45,064 shares of the company’s stock after buying an additional 5,136 shares during the quarter. iA Global Asset Management Inc.’s holdings in HCA Healthcare were worth $19,206,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in HCA. Chung Wu Investment Group LLC bought a new position in HCA Healthcare during the second quarter worth about $27,000. Clearstead Trust LLC grew its stake in HCA Healthcare by 311.8% in the 2nd quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after buying an additional 53 shares in the last quarter. Ameriflex Group Inc. purchased a new stake in shares of HCA Healthcare during the second quarter worth $27,000. Harbor Capital Advisors Inc. raised its stake in shares of HCA Healthcare by 82.9% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after purchasing an additional 34 shares during the period. Finally, Twin Peaks Wealth Advisors LLC bought a new position in HCA Healthcare in the 2nd quarter worth about $40,000. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Trading Up 0.1%

Shares of NYSE HCA opened at $466.10 on Friday. HCA Healthcare, Inc. has a 1-year low of $295.00 and a 1-year high of $520.00. The stock’s 50-day moving average is $480.40 and its 200 day moving average is $432.89. The stock has a market cap of $106.36 billion, a price-to-earnings ratio of 18.02, a P/E/G ratio of 1.28 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping the consensus estimate of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The firm had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. During the same period last year, the firm posted $4.90 earnings per share. The business’s revenue was up 9.6% compared to the same quarter last year. On average, analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

Insider Activity

In other news, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the transaction, the executive vice president owned 3,487 shares in the company, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.30% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the stock. Raymond James Financial set a $525.00 price objective on shares of HCA Healthcare in a research report on Monday, October 27th. The Goldman Sachs Group upped their price target on shares of HCA Healthcare from $470.00 to $520.00 and gave the stock a “buy” rating in a report on Monday, October 27th. TD Cowen reissued a “buy” rating on shares of HCA Healthcare in a research note on Monday, October 27th. Morgan Stanley downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 price target for the company. in a research report on Monday, December 15th. Finally, KeyCorp reaffirmed an “overweight” rating and issued a $500.00 target price on shares of HCA Healthcare in a research note on Thursday. Fourteen equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $488.75.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.